Outcome Capital is Top 10 Life Science Financial Provider for 2023 awarded by Life Science Review

Outcome Capital is Top 10 Life Science Financial Provider for 2023 awarded by Life Science Review

July 20, 2023

Read the full article here:

News

Outcome Capital Expands Pharmacy and Related Services Board to Enhance Strategic Advisory Capabilities and Drive Value Creation

Outcome Capital, LLC, a highly specialized life sciences and healthcare advisory and investment banking firm, today announced the expansion of its Pharmacy and Related Services Advisory Board.

Read More
Resources

Outcome Capital Life Science Market Pulse

Outcome Capital Life Science Market Pulse December 2025 Click to view our LifeSciences Pulse Newsletter

Download

Contact Us for More Information

Would you like to learn more about working with Outcome Capital or discuss your specific needs?

Contact Us

  • Boston

    20 Custom House St, Suite 1200, Boston, MA 02110
    (617) 431-2278

© Outcome Capital 2026. Member of Financial Industry Regulatory Authority (FINRA) and the Securities Investment Protection Corporation (SIPC). Check the background of this firm on FINRA’s BrokerCheck.
Outcome Capital and Outcome Life Sciences are affiliates of Outcome Holdings, LLC

Business Continuity Plan | Privacy Policy | Regulation Best Interest

Built by Metropolis